Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy. [electronic resource]
Producer: 20110728Description: 2150-7 p. digitalISSN:- 1527-7755
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- drug therapy
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Cyclophosphamide -- administration & dosage
- Cytoplasm -- enzymology
- Disease-Free Survival
- Docetaxel
- Doxorubicin -- administration & dosage
- ErbB Receptors -- biosynthesis
- Female
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Multicenter Studies as Topic
- Neoadjuvant Therapy
- Poly(ADP-ribose) Polymerases -- metabolism
- Prognosis
- Randomized Controlled Trials as Topic
- Receptors, Estrogen -- biosynthesis
- Receptors, Progesterone -- biosynthesis
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.